No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SFM240816C85000
- 3.70
- +0.50+15.63%
15min DelayClose Jul 22 16:00 ET
3.70High3.20Low
3.20Open3.20Pre Close183 Volume1.13K Open Interest85.00Strike Price59.66KTurnover47.98%IV6.53%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry3.70Extrinsic Value100Contract SizeAmericanOptions Type0.4713Delta0.0378Gamma23.45Leverage Ratio-0.0886Theta0.0247Rho11.05Eff Leverage0.0872Vega
Intraday
- 5D
- Daily
News
(SFM) - Analyzing Sprouts Farmers Market's Short Interest
Sprouts Farmers Market's (NYSE:SFM) short percent of float has fallen 9.99% since its last report. The company recently reported that it has 9.72 million shares sold short, which is 15.32% of all
Russell Rotation: YTD Market Capitalizations Swelling for Small-caps
Is Sprouts Farmers Market, Inc.'s (NASDAQ:SFM) Recent Stock Performance Tethered To Its Strong Fundamentals?
Sprouts Farmers Market: Producing Good Growth, but Shares Are Inflated
Express News | Evercore ISI Group Maintains In-Line on Sprouts Farmers Market, Raises Price Target to $80
Sprouts Farmers (SFM) Thrives on Product Innovation, Expansion
Comments
Today, we are looking for targets to buy Mon. after Fri's massacre.
$Summit Therapeutics(SMMT.US$
Lung cancer Pharma company's new drug shows tangible improvement over the only other medication for the most common deadly case of lung cancer.
Fundamentals are solid. The PCB is overbought, though. We set our target for $13, but gonna watch this one close. Pharma be fickle.
$A10 Networks(ATEN.US$
I feel is strongest of the day. They make software for things like data-center optimization. Wonde...
$Summit Therapeutics(SMMT.US$
Lung cancer Pharma company's new drug shows tangible improvement over the only other medication for the most common deadly case of lung cancer.
Fundamentals are solid. The PCB is overbought, though. We set our target for $13, but gonna watch this one close. Pharma be fickle.
$A10 Networks(ATEN.US$
I feel is strongest of the day. They make software for things like data-center optimization. Wonde...
4
Investors' belief in Sprouts Farmers Market's continued market outperformance likely causes its high P/E ratio. However, with forecast growth only matching the wider market, the high P/E ratio may be unjustified, risking a share price decline. The current earnings growth level may also pressure the share price.
1
Significant insider selling at Sprouts Farmers Market may suggest insiders believe the shares are overpriced. Despite profitability and growth, the absence of insider buying and low insider ownership could caution potential investors.
Sprouts, a leading specialty grocer, has shown resilience despite grocery business challenges. Its quarterly performance was boosted by higher-than-anticipated same-store sales growth and fewer new store openings. The company's same-store sales growth and annual earnings forecast surpassed Wall Street's predictions. The stock rose 3.3% post-reporting.
1
The market's opinion of the business has improved over the past five years due to its growth track record. The stock's recent performance and strong share price momentum suggest it may be worth a closer look.
Read more